Table 6. Inclusion criteria for TARGIT-C trial.
Age ≥50 years |
Invasive-ductal breast cancer |
Hormone receptor positive |
Tumour size ≤3.5 cm cN0 cM0 |
≥50 years of age |
Compliance and informed consent |
Age ≥50 years |
Invasive-ductal breast cancer |
Hormone receptor positive |
Tumour size ≤3.5 cm cN0 cM0 |
≥50 years of age |
Compliance and informed consent |